# Study on the Role of Human Serum Albumin in Large Acute Ischemic Stroke of Anterior Circulation After Thrombectomy

> **NCT06629116** · NA · RECRUITING · sponsor: **Tingyu-Yi** · enrollment: 100 (estimated)

## Conditions studied

- Cerebral Ischemia

## Interventions

- **DRUG:** Patients with AIS receive intravascular therapy, and within 10 minutes after the surgery, they are administered 100ml of 20% human albumin intravenously (infused within 30 minutes).

## Key facts

- **NCT ID:** NCT06629116
- **Lead sponsor:** Tingyu-Yi
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-30
- **Primary completion:** 2026-12-30
- **Final completion:** 2027-05-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06629116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06629116, "Study on the Role of Human Serum Albumin in Large Acute Ischemic Stroke of Anterior Circulation After Thrombectomy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06629116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*